ACD/Labs' Physicochemical Property Prediction Tools Deployed Across GSK's Global Discovery Research Facilities
Toronto, Canada, June 20, 2005 -
Advanced Chemistry Development, Inc., (ACD/Labs) is pleased to announce further deployment of a complete array of ACD/Labs' physicochemical property prediction software tools across GlaxoSmithKline (GSK) research centers in the United States of America, Europe, and Japan.
Dr. Drake Eggleston, VP of Computational, Analytical & Structural Sciences at GSK states, "We are excited about the evolving collaboration with ACD/Labs which represents one component of enhancement to our capabilities in the design and discovery of new medicines for many indications involving a variety of target classes and diverse chemotypes."
Dr. Antony Williams, Chief Science Officer at ACD/Labs, adds, "Our colleagues in pharmaceutical R&D laboratories are conscious of the fact that physical properties such as hydrophobicity, acid/base behavior, and solubility are crucial in the performance of active pharmaceutical agents. With continuing pressure on large pharmaceutical companies to deliver new drugs to markets, ACD/Labs tools are becoming increasingly important as support tools for their investigations. We are excited to both support and collaborate with scientists at GSK to ensure that our PhysChem solutions deliver to their needs."
The Batch version of ACD/LogD Suite will enable Discovery Scientists to automatically predict the pH-dependent measure of hydrophobicity, logD, as well as pKa, logP values, and related parameters for tens of thousands of compounds at a time with minimal operator intervention.
While standalone versions of the software were provided to specialists, ACD/LogD Suite Batch was also customized for worldwide accessibility through GSK's graphical user interface. The entire suite of ACD/PhysChem Batch products is available to run on Microsoft® Windows®, SUN®, and Linux platforms.
1D and 2D NMR verification and processing tools from ACD/Labs have also recently been deployed onto the desktops of Discovery Scientists and specialists at GSK.
About Advanced Chemistry Development
Advanced Chemistry Development, Inc., (ACD/Labs) is a chemistry software company offering solutions that truly integrate chemical structures with analytical chemistry information to produce ChemAnalytics®. ACD/Labs creates innovative software packages that aid chemical research scientists worldwide with spectroscopic validation of structures, elucidation of unknown substances, chromatographic separation, medicinal chemistry, preformulation of novel drug agents, systematic nomenclature generation, and chemical patenting and publication. Combined, ACD/Labs' solutions create an analytical informatics system that provides dramatic feed-forward effects on the chemical and pharmaceutical research process. Founded in 1993, and headquartered in Toronto, Canada, ACD/Labs employs a team of over 100 dedicated individuals whose continual efforts carry ACD/Labs' innovative technologies into pharmaceutical, biotech, chemical, and materials companies throughout the world. Information about Advanced Chemistry Development and its products can be found at www.acdlabs.com.
|
